PROKIDNEY CORP.
PROKNasdaqHealthcare · Biological Products, (No Diagnostic Substances) · E9 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | |
|---|---|---|---|---|---|
| Revenue | $893,000 | $76,000 | $0 | $0 | — |
| Operating income | −$165.0M | −$183.7M | −$151.5M | −$153.0M | −$2.3M |
| Net income | −$69.0M | −$61.2M | −$35.5M | −$54.5M | −$2.3M |
| Total assets | $335.6M | $441.1M | $420.6M | $518.0M | $251.2M |
| Total liabilities | $34.8M | $39.4M | $29.2M | $13.1M | $9.6M |
| Equity | −$1.01B | −$995.0M | −$1.10B | −$1.10B | $0 |
| EPS (diluted) | — | — | — | $-0.23 | — |
| Shares out. | — | — | — | 61.5M | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −18477.8%
- Net margin
- −7725.2%
- Return on equity
- 6.8%
- Return on assets
- −20.6%
- Return on capital (ROCE)
- −54.1%
- Liabilities / assets
- 10.4%
- Debt / equity
- —
- Book value / share
- —
- Revenue growth (YoY)
- 1075.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -41.28distress
- Accruals / assets
- 15.2%high accruals
- Piotroski F-Score
- 2/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 4 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- High accruals — earnings-quality risk
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Clinical trials
ClinicalTrials.gov · ongoing · next readout firstInterventional studies led by this company. “Readout” is the trial's primary-completion date — an estimate the sponsor reports, not a guarantee.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 19.2M | 25.2 | +5.4% |
| Apr 30, 2026 | 18.3M | 27.5 | +3.8% |
| Apr 15, 2026 | 17.6M | 12.8 | +5.5% |
| Mar 31, 2026 | 16.7M | 18.2 | +8.8% |
| Mar 13, 2026 | 15.3M | 25.2 | -1.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Shareholder voteMay 29, 2026
- Results of operations · Regulation FD disclosure · Other material eventMay 15, 2026
- Results of operationsMar 18, 2026
- Regulation FD disclosure · Other material eventFeb 2, 2026
- Regulation FD disclosureJan 12, 2026
- Results of operationsNov 10, 2025
- Entered a material agreementOct 17, 2025
- Results of operationsAug 12, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (4)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.